Brief: Aequus To Broaden Vistitan Reimbursement For Patients In Canada
10/01/2020 14:32
Jan 10 (Reuters) - Aequus Pharmaceuticals Inc AQS.V :
* AEQUUS TO BROADEN VISTITAN REIMBURSEMENT FOR PATIENTS IN
CANADA
* AEQUUS PHARMACEUTICALS - WILL PROVIDE A FURTHER UPDATE ON
ANTICIPATED LAUNCH TIMELINES FOR EVOLVE BY END OF JANUARY
Source text for Eikon: ID:nGNXll5lZ
Further company coverage: AQS.V
((Briefs@thomsonreuters.com;))
Recent news on Aequus Pharmaceuticals
See all newsBrief: Aequus Pharmaceutical Canada Pauses Sales Of Evolve Intensive Eyedrops, Gel In Canada
Brief: Aequus Announces Financing To Support Launch Of Zimed Preservative Free (Bimatoprost 0.03%) And Board Update
Brief: Aequus Announces Health Canada Notice Of Compliance For Zimed® Preservative Free
Brief: Aequus Announces Sandoz Contract Expiry At Year End And Expected Health Canada Approval For Zimed® Pf (Preservative Free)
Brief: Aequus Resumes Trading On TSX Venture Exchange